We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Bacteriophage Therapy Eliminates Multidrug Resistant Bacterial Infections

By LabMedica International staff writers
Posted on 01 Mar 2015
Print article
Image: Bacteriophage EFDG1 visualized by transmission electron microscopy (TEM) at a magnification of 20,000–30,000 times. Note that some phages are still bound to remains of the dead bacteria (Photo courtesy of the Hebrew University of Jerusalem).
Image: Bacteriophage EFDG1 visualized by transmission electron microscopy (TEM) at a magnification of 20,000–30,000 times. Note that some phages are still bound to remains of the dead bacteria (Photo courtesy of the Hebrew University of Jerusalem).
Bacteriophage therapy has been shown to be an effective approach for treating infections caused by drug-resistant strains of the bacterium Enterococcus faecalis.

E. faecalis, a bacterium inhabiting the gastrointestinal tracts of humans, is an important pathogen found in many infections including endocarditis, urinary tract infection, meningitis, and persistent infections associated with root canal treatment failure. The difficulty in E. faecalis treatment has been attributed to the lack of anti-infective strategies to eradicate its biofilm and to the frequent emergence of multidrug resistant strains.

Investigators at the Hebrew University of Jerusalem (Israel) evaluated the possibility of treating E. faecalis infections with specific bacteriophages, viruses that infect and destroy bacteria. To this end, they isolated an anti-E. faecalis and E. faecium phage, from effluents obtained from a Jerusalem (Israel), sewage treatment facility.

The EFDG1phage was visualized by electron microscopy. EFDG1 DNA coding sequences and phylogeny were determined by whole genome sequencing, which revealed that it belonged to the Spounavirinae subfamily of the Myoviridae phages, which includes promising candidates for therapy against Gram positive pathogens. This analysis also showed that the EFDG1 genome did not contain apparent harmful genes.

EFDG1 antibacterial efficacy was evaluated in vitro against planktonic and biofilm cultures. Results published in the February 6, 2015, online edition of the journal Applied and Environmental Microbiology showed that the phage displayed effective lytic activity against various E. faecalis and E. faecium isolates, regardless of their antibiotic resistance profile. Additionally, EFDG1 efficiently prevented ex vivo E. faecalis root canal infection.

Senior author Dr. Ronen Hazan, professor of dental sciences at the Hebrew University of Jerusalem, said, “The idea of using phages as antibacterial drugs is not new. Phage therapy was first proposed at the start of the 20th century, but then abandoned for various reasons, including the striking success of chemical antibiotics. Now we stand on the verge of a new era with the limitations of synthetic antibiotics and the emergence of antibiotic-resistant strains of bacteria. Thus it is the right time to look again into what Mother Nature offers in the battle against bacteria. As this research shows, bacteriophages may prove an effective tool in the development of much-needed new antimicrobial drugs.”

Hebrew University of Jerusalem

Related Links:
New
Gold Member
Syphilis Screening Test
VDRL Antigen MR
Automated Blood Typing System
IH-500 NEXT
New
Chemistry Analyzer
MS100
New
Liquid Based Cytology Production Machine
LBP-4032

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.